Correlation Between Caribou Biosciences and VTv Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and VTv Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and VTv Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and vTv Therapeutics, you can compare the effects of market volatilities on Caribou Biosciences and VTv Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of VTv Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and VTv Therapeutics.

Diversification Opportunities for Caribou Biosciences and VTv Therapeutics

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Caribou and VTv is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and vTv Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on vTv Therapeutics and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with VTv Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of vTv Therapeutics has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and VTv Therapeutics go up and down completely randomly.

Pair Corralation between Caribou Biosciences and VTv Therapeutics

Given the investment horizon of 90 days Caribou Biosciences is expected to under-perform the VTv Therapeutics. In addition to that, Caribou Biosciences is 1.07 times more volatile than vTv Therapeutics. It trades about -0.09 of its total potential returns per unit of risk. vTv Therapeutics is currently generating about 0.08 per unit of volatility. If you would invest  1,418  in vTv Therapeutics on September 23, 2024 and sell it today you would earn a total of  78.00  from holding vTv Therapeutics or generate 5.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Caribou Biosciences  vs.  vTv Therapeutics

 Performance 
       Timeline  
Caribou Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Caribou Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental drivers, Caribou Biosciences is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
vTv Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in vTv Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, VTv Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Caribou Biosciences and VTv Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Caribou Biosciences and VTv Therapeutics

The main advantage of trading using opposite Caribou Biosciences and VTv Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, VTv Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VTv Therapeutics will offset losses from the drop in VTv Therapeutics' long position.
The idea behind Caribou Biosciences and vTv Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Stocks Directory
Find actively traded stocks across global markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum